Full-Service Contract Research Organization (CRO)

aCROss Medical
We Deliver Results
Not Just Run Trials.

Because we've been on your side of the table.

Clinical trial sites map across Georgia, Armenia, Israel and Uzbekistan Tbilisi HQ Yerevan Tel Aviv Tashkent
0+
Clinical Trials Completed
0+
Dedicated Clinical Centers
0+
Years Experience
0%
Study Success Rate
Peer-Reviewed. Independently Published.

Highlights From Our Work, In the World's Leading Journals.

Peer-reviewed publications representing just a portion of the trials we've led and delivered.

View Our Clinical Evidence
Published In
The Lancet JACC Ophthalmology Stroke BMJ Cornea EJHF Cytotherapy Critical Care Explorations J Clin Med

What We Cover

Med Devices
FIH - Pivotal
Pharma
Phase I - IV
Advanced Therapies
Cell & Gene
All Phases
Phase I - IV
ICU Stem Cells General Surgery Infectious Disease OBGYN Oncology Respiratory Vascular
Center of Excellence

aCROss Vision

With a significant track record across multiple ophthalmology subspecialties - from glaucoma to retina, cornea to ocular implants.

Learn More
aCROss Vision

Key Challenges in Clinical Trials

Regulatory delays, enrollment slowdowns, and high costs can lead to project standstill and significant budget overruns.

Lengthy Regulatory Timelines

US and EU regulatory approvals can take 6-8 months, delaying your study start and increasing time-to-market.

Slow Patient Enrollment

Overextended clinical staff and competitive site landscapes lead to slow enrollment across Western markets.

High Operational Costs

Rising study budgets in the US and Europe create significant financial pressure, especially for smaller sponsors.

Why Choose Our Territories?

aCROss Medical offers a faster, more efficient alternative - run your clinical trial in our territories with us.

Benefit Georgia, Armenia, Israel & Uzbekistan Europe & US
Regulatory Process Fast approval (6-8 weeks) Lengthy approval
Research Teams Skilled & motivated clinical staff Experienced but often overextended
Enrollment Speed Fast enrollment across study sites Slow enrollment
Data Acceptance Accepted by EU & US agencies Accepted by EU & US agencies
Cost Efficiency Competitive study budgets High costs

Client Testimonials

Ophthalmology
BELKIN Vision collaborated with Across Medical on several projects, and the experience was consistently productive and efficient. The team was responsive, professional, and worked seamlessly on study, regulatory, site interactions and translations.
Cardiology
Evaluating Georgia for our clinical study was a strategic exercise that exceeded our expectations, thanks to the team at aCROss Medical. Yoram and Alio went far beyond standard CRO services, thoughtfully aligning clinical strategy with our long-term regulatory goals in Europe and the US. They delivered a qualitatively high-value roadmap that prioritized ethical soundness and timely execution. A standout moment was their rapid mobilization of the local clinical network; we were able to conduct several deep-dive sessions with Tbilisi-based specialists on very short notice. Ultimately, aCROss helped us reach a critical decision: for this specific study, the unique transplant policy features we required were only available in the US. The fact that aCROss helped us arrive at this 'right' conclusion - rather than simply pushing their local services - speaks volumes about their integrity. For any medical device company weighing international clinical options, aCROss is an indispensable partner.
Orthopedics
aCROss Medical understood our challenges from day one. Their team didn't just manage the trial - they anticipated issues before they became problems. First site was initiated weeks ahead of schedule.
Orthopedics
We partnered with aCROss Medical on a study that required a broad range of services, from site identification and feasibility through to patient recruitment, data management and ongoing monitoring activities. Throughout, their team was readily available and consistently open to discussion. Most notably, they ensured we not only met but exceeded our ambitious targets for patient recruitment - underlying them as a strong and highly reliable partner for clinical research activities.
Ophthalmology
At CorNeat Vision, we knew that taking our human feasibility study outside the U.S. would be a massive undertaking. We didn't just need a CRO; we needed a partner who knew the local landscape as well as we know our own technology. Across Medical was that partner. From day one, they brought a level of operational rigor that gave us immediate peace of mind. What really stood out wasn't just their technical command of regulatory requirements - it was how they treated our goals as their own. They didn't just flag problems; they solved them before they could impact our timeline. Working with their team felt less like managing a vendor and more like adding a dedicated wing to our internal staff. They are professional, incredibly responsive, and genuinely kind people. I can say with total confidence that our program advanced faster and smoother because Across Medical was in our corner.
Acute Ischemic Stroke
aCROss Medical built an operational infrastructure that addressed every challenge, from site qualification and hands-on procedural training to true 24/7 activation readiness. What initially seemed impossible on paper became a smoothly running trial. The study involved highly complex operational demands, requiring continuous 24/7 readiness and precise coordination between multiple stakeholders - all executed with professionalism and strict adherence to timelines.
Ophthalmology
What sets aCROss apart is the physician-led approach. Having MDs who understand both the science and the operational reality made a real difference in our ophthalmology program across Georgia and Armenia.
Cardiology
As a startup with limited budget, we needed a CRO that could deliver quality without the overhead of a large organization. aCROss Medical gave us exactly that - personal attention, fast timelines, and high-quality data accepted by the FDA for our pivotal trial.
Cell Therapy
aCROss was introduced to us through a mutual connection. At the outset of our trial, we had limited experience working outside the U.S. regulatory environment and needed to familiarize ourselves with the processes and operational landscape in Georgia. However, those initial uncertainties were quickly resolved after meeting the aCROss team. From the very beginning of our collaboration, it became clear that this would be more than a typical CRO partnership; it would be a true team effort. To us, aCROss represents professionalism, dedication, and exceptional availability. We have full confidence in their expertise and judgment in all aspects of our study. We now look forward to continuing this successful collaboration in Phase 3.
ICU
Across Medical was an outstanding partner for PATH EX in executing our human feasibility study outside the United States. As a U.S.-based company operating in a complex international regulatory and clinical environment, we relied heavily on their expertise - and they delivered at every stage. Their team demonstrated strong local knowledge, efficient site coordination, and a clear understanding of both clinical and regulatory expectations, enabling a smooth and timely study startup. Across Medical was highly responsive, detail-oriented, and proactive in addressing challenges, making them a trusted extension of our team. Their support was instrumental in advancing our technology, and we would confidently recommend them to other companies pursuing international clinical studies.
Ophthalmology
BELKIN Vision collaborated with Across Medical on several projects, and the experience was consistently productive and efficient. The team was responsive, professional, and worked seamlessly on study, regulatory, site interactions and translations.
Cardiology
Evaluating Georgia for our clinical study was a strategic exercise that exceeded our expectations, thanks to the team at aCROss Medical. Yoram and Alio went far beyond standard CRO services, thoughtfully aligning clinical strategy with our long-term regulatory goals in Europe and the US. They delivered a qualitatively high-value roadmap that prioritized ethical soundness and timely execution. A standout moment was their rapid mobilization of the local clinical network; we were able to conduct several deep-dive sessions with Tbilisi-based specialists on very short notice. Ultimately, aCROss helped us reach a critical decision: for this specific study, the unique transplant policy features we required were only available in the US. The fact that aCROss helped us arrive at this 'right' conclusion - rather than simply pushing their local services - speaks volumes about their integrity. For any medical device company weighing international clinical options, aCROss is an indispensable partner.
Orthopedics
aCROss Medical understood our challenges from day one. Their team didn't just manage the trial - they anticipated issues before they became problems. First site was initiated weeks ahead of schedule.
Orthopedics
We partnered with aCROss Medical on a study that required a broad range of services, from site identification and feasibility through to patient recruitment, data management and ongoing monitoring activities. Throughout, their team was readily available and consistently open to discussion. Most notably, they ensured we not only met but exceeded our ambitious targets for patient recruitment - underlying them as a strong and highly reliable partner for clinical research activities.
Ophthalmology
At CorNeat Vision, we knew that taking our human feasibility study outside the U.S. would be a massive undertaking. We didn't just need a CRO; we needed a partner who knew the local landscape as well as we know our own technology. Across Medical was that partner. From day one, they brought a level of operational rigor that gave us immediate peace of mind. What really stood out wasn't just their technical command of regulatory requirements - it was how they treated our goals as their own. They didn't just flag problems; they solved them before they could impact our timeline. Working with their team felt less like managing a vendor and more like adding a dedicated wing to our internal staff. They are professional, incredibly responsive, and genuinely kind people. I can say with total confidence that our program advanced faster and smoother because Across Medical was in our corner.
Acute Ischemic Stroke
aCROss Medical built an operational infrastructure that addressed every challenge, from site qualification and hands-on procedural training to true 24/7 activation readiness. What initially seemed impossible on paper became a smoothly running trial. The study involved highly complex operational demands, requiring continuous 24/7 readiness and precise coordination between multiple stakeholders - all executed with professionalism and strict adherence to timelines.
Ophthalmology
What sets aCROss apart is the physician-led approach. Having MDs who understand both the science and the operational reality made a real difference in our ophthalmology program across Georgia and Armenia.
Cardiology
As a startup with limited budget, we needed a CRO that could deliver quality without the overhead of a large organization. aCROss Medical gave us exactly that - personal attention, fast timelines, and high-quality data accepted by the FDA for our pivotal trial.
Cell Therapy
aCROss was introduced to us through a mutual connection. At the outset of our trial, we had limited experience working outside the U.S. regulatory environment and needed to familiarize ourselves with the processes and operational landscape in Georgia. However, those initial uncertainties were quickly resolved after meeting the aCROss team. From the very beginning of our collaboration, it became clear that this would be more than a typical CRO partnership; it would be a true team effort. To us, aCROss represents professionalism, dedication, and exceptional availability. We have full confidence in their expertise and judgment in all aspects of our study. We now look forward to continuing this successful collaboration in Phase 3.
ICU
Across Medical was an outstanding partner for PATH EX in executing our human feasibility study outside the United States. As a U.S.-based company operating in a complex international regulatory and clinical environment, we relied heavily on their expertise - and they delivered at every stage. Their team demonstrated strong local knowledge, efficient site coordination, and a clear understanding of both clinical and regulatory expectations, enabling a smooth and timely study startup. Across Medical was highly responsive, detail-oriented, and proactive in addressing challenges, making them a trusted extension of our team. Their support was instrumental in advancing our technology, and we would confidently recommend them to other companies pursuing international clinical studies.

Frequently Asked Questions

Everything our partners ask before starting a study with us.

Why run clinical trials in Georgia, Armenia or Uzbekistan instead of Western Europe?
Running clinical trials in Georgia, Armenia or Uzbekistan offers three major advantages over Western Europe and the US: regulatory approval in 6-8 weeks (vs. 6-8 months), significantly lower operational costs, and access to large treatment-naive patient populations. Data generated in these countries is accepted by the FDA and European authorities, making them ideal for international sponsors looking to accelerate timelines without compromising on quality.
How long does study start-up take with aCROss Medical?
aCROss Medical achieves site initiation within 6-8 weeks from study start - significantly faster than the US or EU. Our established relationships with over 40 dedicated clinical centers and our physician-led team allow us to move quickly from feasibility to first patient in.
What phases of clinical trials does aCROss Medical manage?
aCROss Medical manages clinical trials across all phases - Phase I through Phase IV, including First-in-Human (FIH) studies. Our experience spans medical devices, pharmaceutical trials, (from FIH to pivotal CE mark studies) and advanced therapy medicinal products (ATMPs), including cell and gene therapy.
Is data from Georgia, Armenia, Israel and Uzbekistan accepted by the FDA and European authorities?
Yes. Clinical trial data from all four of our operating countries is accepted by both the FDA and European authorities. Our sites operate in full compliance with ICH-GCP guidelines and our studies have been successfully inspected by international regulatory authorities. Results have been published in The Lancet, JACC, BMJ and other leading journals.
What therapeutic areas does aCROss Medical cover?
aCROss Medical covers cardiology, ophthalmology (glaucoma, retina, cornea and ocular implants), orthopedics, neurology, urology, oncology, infectious disease, respiratory, vascular and general surgery. We also conduct ICU and stem cell studies.
What makes aCROss Medical different from other CROs?
aCROss Medical was founded by former sponsors, which means we approach every study with a sponsor's mindset - not just as a service provider. Our physician-led team of local and international MDs stays personally involved in every study. With 20+ years of experience, 70+ completed trials and a 95% regulatory audit success rate, we combine scientific expertise with operational efficiency to deliver results, not just run trials.

Ready to Start Your Clinical Study?

Choose a faster, more cost-effective path for your trial in Georgia, Armenia, Israel and Uzbekistan.

Get In Touch